Showing results (1861-1870 of 2,135) with videos related to
Sort By:
Pageof 214
Cancer Discovery|August 8, 2014
ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agentsSameer Agnihotri, Kelly Burrell, Pawel Buczkowicz, et al.Plos One|November 28, 2017
Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesionDavid Reyes-Corona, Nallely Vázquez-Hernández, Lourdes Escobedo, et al.Advanced Materials (Deerfield Beach, Fla.)|March 9, 2016
Redox-Active Metal-Organic Composites for Highly Selective Oxygen Separation ApplicationsWen Zhang, Debasis Banerjee, Jian Liu, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 5, 2012
A form of apolipoprotein a-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantationJ Lopez-Hellin, C Cantarell, L Jimeno, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 5, 1977
A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicinW du T Naudé, J van den Ende, P Botha, et al.Physical Review Letters|November 13, 2008
Nonequilibrium spin-glass dynamics from picoseconds to a tenth of a secondF Belletti, M Cotallo, A Cruz, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentA Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.Neuroimage|March 31, 2015
Multi-vendor reliability of arterial spin labeling perfusion MRI using a near-identical sequence: implications for multi-center studiesHenri J M M Mutsaerts, Matthias J P van Osch, Fernando O Zelaya, et al.Vital and Health Statistics. Series 2, Data Evaluation and Methods Research|November 20, 2014
Linkage of 1986-2009 National Health Interview Survey with 1981-2010 Florida Cancer Data SystemEric A Miller, Donna M Miller, Dean H Judson, et al.ESMO Open|June 13, 2025
Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374)V Gambardella, M K Accordino, P L Bedard, et al.Pageof 214